newsfilter
← Latest News
GlobeNewswire·

Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights

CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (NASDAQ:AKBA) today announced plans to release its financial results for the third quarter ended September 30, 2025, on Monday,